Comparison of oncologic outcomes of metastatic rectal cancer patients with or without neoadjuvant chemoradiotherapy

被引:0
|
作者
So Hyun Kim
Jae Hwang Kim
Sang Hun Jung
机构
[1] Yeungnam University,Department of Surgery, College of Medicine
来源
International Journal of Colorectal Disease | 2015年 / 30卷
关键词
Rectal neoplasms; Neoadjuvant chemoradiotherapy; Metastases; Stage IV;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1193 / 1199
页数:6
相关论文
共 50 条
  • [31] Prognostic Significance of Clinicopathological and Molecular Features After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients
    Cho, Hee Jeong
    Baek, Jin Ho
    Baek, Dong Won
    Kang, Byung Woog
    Lee, Soo Jung
    Kim, Hye Jin
    Park, Su Yeon
    Park, Jun Seok
    Choi, Gyu Seog
    Kim, Jong Gwang
    IN VIVO, 2019, 33 (06): : 1959 - 1965
  • [32] Adjuvant versus neoadjuvant chemoradiotherapy in distal rectal cancer: Comparison of two decades in a single center
    Zengel, Baha
    Uslu, Adam
    Adibelli, Zehra
    Yetis, Halit
    Cengiz, Fevzi
    Aykas, Ahmet
    Simsek, Cenk
    Akpinar, Goksever
    Eliyatkin, Nuket
    Duran, Ali
    TURKISH JOURNAL OF SURGERY, 2015, 31 (04) : 218 - 223
  • [33] Possible predictors of histopathological response to neoadjuvant chemoradiotherapy for rectal cancer
    Farkas, Robert
    Pozsgai, Eva
    Schally, Andrew V.
    Szigeti, Andras
    Szigeti, Edit
    Laszlo, Zoltan
    Papp, Andras
    Gomori, Eva
    Mangel, Laszlo
    Horvath, Peter O.
    Bellyei, Szabolcs
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (03) : 387 - 395
  • [34] Neoadjuvant Chemotherapy Rather than Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer with High Tumor Burden
    Koca, Dogan
    Oztop, Ilhan
    Yilmaz, Ugur
    HEPATO-GASTROENTEROLOGY, 2012, 59 (119) : 2151 - 2154
  • [35] Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
    McCoy, Melanie J.
    Hemmings, Chris
    Hillery, Simon
    Penter, Cheryl
    Bulsara, Max K.
    Zeps, Nik
    Platell, Cameron F.
    ANZ JOURNAL OF SURGERY, 2017, 87 (12) : E233 - E239
  • [36] Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer
    Ozturk, Sonay K.
    Martinez, Cristina G.
    Mens, David
    Verhoef, Cornelis
    Tosetto, Miriam
    Sheahan, Kieran
    de Wilt, Johannes H. W.
    Hospers, Geke A. P.
    van de Velde, Cornelis J. H.
    Marijnen, Corrie A. M.
    van Der Post, Rachel S.
    Nagtegaal, Iris D.
    HISTOPATHOLOGY, 2024, 84 (06) : 935 - 946
  • [37] Possible predictors of histopathological response to neoadjuvant chemoradiotherapy for rectal cancer
    Robert Farkas
    Eva Pozsgai
    Andrew V. Schally
    Andras Szigeti
    Edit Szigeti
    Zoltan Laszlo
    Andras Papp
    Eva Gomori
    Laszlo Mangel
    Peter O. Horvath
    Szabolcs Bellyei
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 387 - 395
  • [38] Matched case-control analysis comparing oncologic outcomes between preoperative and postoperative chemoradiotherapy for rectal cancer
    Lee, Byoung Chul
    Park, In Ja
    Kim, Chan Wook
    Lim, Seok-Byung
    Yu, Chang Sik
    Kim, Jin Cheon
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2017, 92 (04) : 200 - 207
  • [39] Long-term oncologic outcomes of neoadjuvant concurrent chemoradiotherapy with capecitabine and radical surgery in locally advanced rectal cancer: 10-year experiences at a single institution
    Lee, Kyung Ha
    Kim, Jin Soo
    Kim, Ji Yeon
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2016, 91 (04) : 178 - 186
  • [40] Comprehensive malnutritional index for predicting clinical outcomes in locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy
    Xu, Yu
    Shen, Peipei
    Zhu, Jiahao
    Qian, Danqi
    Gu, Ke
    Mao, Yong
    Ji, Shengjun
    Yang, Bo
    Zhao, Yutian
    BIOMOLECULES AND BIOMEDICINE, 2024, : 1079 - 1091